Liposome Tech regulatory update

Liposome Technology Inc. (LTIZ) LTIZ (Menlo Park, Calif.) filed for Israeli approval of Amphocil, its lipid-complexed formulation of amphotericin B. The company is seeking approval to treat severe sy...